Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.
NCT ID: NCT04874285
Last Updated: 2023-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2021-05-03
2023-05-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions
NCT02016495
The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:
NCT07305519
The Vaginal Progesterone and Cerclage
NCT02846909
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
NCT03636451
Does Oral Magnesium Substitution Relieve Pregnancy Induced Leg Cramps ?
NCT00525317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Women with risk factors for abortion, treated with progesterone
No interventions assigned to this group
study group
Women with risk factors for abortion, treated with progesterone and a dietary supplement containing hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6
HA
hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HA
hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetes or hypertension
* Concomitant pharmacological therapies (anticoagulant or antihypertensive)
* Use of tocolytic drugs two months prior to enrollment
* Association with hypoglycemic drugs
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lo.Li.Pharma s.r.l
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Alma Res
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMW-HA_ABORTION
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.